CEGIR Researchers Report on the FDA Workshop: Challenges, Progress, Questions in Eosinophilic Gastrointestinal Disorders
jaquelyn.freie…
Thu, 01/13/2022 - 08:24
Marc Rothenberg, MD, PhD, with a future researcher of eosinophilic disease
The U.S. Food and Drug Administration (FDA) hosted a workshop on July 21, 2021 to discuss the disease characteristics, natural history, and endpoints to assess treatment benefit in patients with eosinophilic gastrointestinal disorders (EGID) beyond eosinophilic esophagitis (EoE).